Figure 3. rVIP treatment down-regulated the TLR4 (A) and IL-17 (C) expression at 3d p.i. LOX-1 expression (B) was up-regulated. MPO levels (D) were decreased in rVIP treated cornea compared with PBS treated cornea after 3 and 5d infection.

^aP<0.001, ^bP<0.05 vs PBS treatment.